PHVS ▲ +2.4% - Pharvaris N.V. $PHVS - Pharvaris Presents Translational, Nonclinical, and Clinical Data at Bradykinin Symposium 2026 Pharvaris rose 2.4% today following the company's presentation of translational, nonclinical, and clinical data on bradykinin-related therapies at Bradykinin Symposium 2026, which likely reinforced investor confidence in its pipeline progress and scientific rationale. 03-SEP-2026 06:50 AM ET